Viracta Therapeutics, Inc.
VIRX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $22,016 | $55,175 | $116,326 | $259,014 |
| - Cash | $12,317 | $36,773 | $103,554 | $47,089 |
| + Debt | $25,556 | $25,155 | $5,478 | $6,178 |
| Enterprise Value | $35,255 | $43,557 | $18,250 | $218,103 |
| Revenue | $0 | $0 | $0 | $120 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$492 | -$210 | -$178 | $88 |
| % Margin | – | – | – | 73.3% |
| EBITDA | -$46,862 | -$48,410 | -$114,093 | -$18,769 |
| % Margin | – | – | – | -15,640.8% |
| Net Income | -$51,058 | -$49,774 | -$203,062 | -$19,199 |
| % Margin | – | – | – | -15,999.2% |
| EPS Diluted | -1.32 | -1.32 | -6.37 | -0.52 |
| % Growth | 0% | 79.3% | -1,125% | – |
| Operating Cash Flow | -$39,892 | -$35,457 | -$18,851 | -$16,054 |
| Capital Expenditures | -$138 | -$45 | -$4,252 | -$55 |
| Free Cash Flow | -$40,030 | -$35,502 | -$23,103 | -$16,109 |